MONTGOMERY, Ala. (WDNews) – Alabama Attorney General Steve Marshall has announced the state’s latest legal victory in the nationwide fight against the opioid epidemic, securing $11.725 million from eight pharmaceutical companies accused of contributing to the opioid crisis. The funds will be distributed with full participation from local governments, public hospitals, and other agencies.
“This settlement marks another pivotal achievement in Alabama’s aggressive and uniquely successful legal strategy to hold opioid manufacturers, distributors, and others accountable,” said Attorney General Marshall. “Our states have faced unimaginable loss due to the widespread abuse and misuse of opioids, and we have responded with decisive legal action.”
The settlement includes payments from the following companies:
Mylan (now Viatris): $284.4 million over 9 years
Hikma: $95.8 million over 1 to 4 years
Amneal: $71.7 million over 10 years
Apotex: $63.6 million in a single year
Indivior: $38 million over 4 years
Sun: $30.9 million over 1 to 4 years
Alvogen: $18.6 million in a single year
Zydus: $14.8 million in a single year
The settlements also include added conditions. Seven of the eight companies—excluding Indivior—will be prohibited from marketing opioids, making or selling pills containing more than 40mg of oxycodone, and are required to monitor and report suspicious orders. Indivior has agreed to halt opioid manufacturing and sales for the next 10 years but may continue offering medications to treat opioid use disorder.
Some states may also receive additional free products or cash substitutes under the agreements.
